Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04428333 · TERMINATED
Trial details
- NCT number
- NCT04428333
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2021-04-27
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.